797
Views
7
CrossRef citations to date
0
Altmetric
Original Articles

Development of a Nomogram to Predict the Risk of 30-Day Re-Exacerbation for Patients Hospitalized for Acute Exacerbation of Chronic Obstructive Pulmonary Disease

ORCID Icon, , , , , , & ORCID Icon show all
Pages 160-167 | Received 28 Oct 2018, Accepted 02 Apr 2019, Published online: 16 May 2019
 

Abstract

Acute exacerbation (AE) is the main cause of increased disability and mortality for patients with Chronic Obstructive Pulmonary Disease (COPD). Short-term re-exacerbation after discharge is common for in-hospital patients with AECOPD. Thus, we aimed to design a scoring system to effectively predict the 30-day re-exacerbation using simple and easily accessible variables. We retrospectively enrolled 686 cases hospitalized for AECOPD in two Chinese hospitals from 2005 to 2017. A variety of parameters were collected like demographics, clinical manifestations and treatments in stable and AE period. The optimal subset of covariates in the multivariate logistic analysis was identified by the smallest Akaike Information Criterion (AIC) and was further used to develop a practical and reliable nomogram to predict the 30-day re-exacerbation. The efficacy of the nomogram was internally validated by concordance index (C-index) and a calibration plot. The incidence of 30-day re-exacerbation was 15.8%. Based on the smallest AIC, eight easily-accessible parameters were included in the nomogram, including sex, COPD assessment test (CAT) scores, AE with respiratory failure in the previous year, new purulent sputum, new cardiovascular events, combined antibiotic therapy, theophylline therapy for AE and ICU admission. Our nomogram revealed good discriminative ability with the C-index of 0.702. The calibration curve showed good agreement between nomogram-predicted probability and actual observation. Incorporating eight common variables, a nomogram for 30-day re-exacerbation after discharge with high predictive performance was constructed for patients with AECOPD, which was helpful in predicting individualized risk of re-exacerbation and offering individualized post-discharge support.

Acknowledgments

The authors would like to acknowledge Dr Shi Xiao who critically reviewed the article for English writing.

Disclosure

The authors report no conflicts of interest in this work.

Author contributions

Study design: Wei-ping Hu, Tsokyi Lhamo, Dong Liu, Jing Zhang; Data Collection: Tsokyi Lhamo, Dong Liu, Jing-qing Hang, Feng-ying Zhang, Yi-hui Zuo, Ying-ying Zeng; Statistical analysis: Wei-ping Hu, Tsokyi Lhamo; Manuscript writing: Wei-ping Hu, Tsokyi Lhamo, Dong Liu, Yi-hui Zuo, Ying-ying Zeng; Critical manuscript revision: Wei-ping Hu, Jing-qing Hang, Feng-ying Zhang, Jing Zhang. All authors read and approved the final manuscript.

Additional information

Funding

This study was supported by the National Key Research and Development Program of China (grant No. 2017YFC1309303 and 2017YFC1309300) and the National Natural Science Foundation of China (grant No. 81670030).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.